Plastic Surgery News and Research

RSS

MicroAire acquires Endotine fixation systems for facial aesthetic surgery

MicroAire Surgical Instruments is pleased to announce the acquisition of Endotine® bioabsorbable, multi-point, soft-tissue fixation systems for facial aesthetic surgery.

20 Aug 2010

Regenicin acquires worldwide exclusive license to know-how technology

Regenicin, Inc., a development stage biotechnology company, announced today that it has completed an initial $3.25 million funding in conjunction with its acquisition of a worldwide exclusive license to know-how technology controlled by Lonza Walkersville ("Lonza Agreement").

18 Aug 2010

Scientist explains way to determine right size for breast implants

"Miami likes glitz",explains Christopher Craft, M.D., which is why women here tend to get larger breast implants in comparison to the rest of the country. Craft attended Georgetown University, graduated from the University of Tennessee Medical School, and completed his plastic surgery training at the University of North Carolina at Chapel Hill. He's a trained general and plastic surgeon specializing in surgical procedures of the body, breasts and skin.

18 Aug 2010

HealthGrades honors Eastern Long Island Hospital with Outstanding Patient Experience Award

Eastern Long Island Hospital (ELIH) is among the top 15 percent in the nation for patient experience based on an analysis of patient surveys from 3,775 hospitals across the country by HealthGrades, the leading independent healthcare ratings organization. By placing in the top 15 percent, ELIH received the 2010/2011 HealthGrades Outstanding Patient Experience Award(TM).

17 Aug 2010

Medical Protective and AAFPRS create new insurance program for facial plastic and reconstructive surgeons

Medical Protective has teamed up with the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) and created The AAFPRS Medical Protective Insurance Program.

17 Aug 2010

PROFIT magazine ranks Prollenium as one of Canada's Fastest Growing Companies

Ario Khoshbin, President of Prollenium Medical Technologies Inc., a privately held specialty medical device company, reported today that his firm will continue to record strong year on year gains in revenues and profitability for its 2010 Fiscal Year ending June 30th. Over the past five years, Prollenium has recorded aggregate revenue growth of more than 524% ranking it amongst Canada's fastest growing firms.

13 Aug 2010

Peter Rullan offers Pixel Perfect skin treatment on Pixel CO2 laser purchase

Founder of the Dermatology Institute, Peter Rullan, M.D., has expanded his practice and is now offering Pixel Perfect™ treatments to his patients with the purchase of the Pixel CO2 laser from Alma Lasers.

13 Aug 2010

Superbug purportedly from Asia on the rise in UK & Australia

British scientists have claimed that a new gene called New Delhi metallo-beta-lactamase, or NDM-1 has emerged that makes the bacteria resistant to almost all antibiotics. India has rejected the claim that it is the source of this superbug. Cases have been detected in the UK and Australia and are on the rise in the UK.

12 Aug 2010

Study examines cosmetic impact of surgical procedure for body dysmorphic disorder

A new study finds that while many who suffer from body dysmorphic disorder (BDD) seek cosmetic procedures, only two percent of procedures actually reduced the severity of BDD. Despite this poor long-term outcome, physicians continue to provide requested surgeries to people suffering from BDD. The study was recently published in Annals of Plastic Surgery.

12 Aug 2010

Theragenics reports consolidated revenue of $20.8M for second-quarter 2010

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the second quarter ended June 30, 2010.

10 Aug 2010

CryoPatch SG pulmonary human cardiac patch receives FDA clearance for 5-year shelf-life extension

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.

9 Aug 2010

ISAPS Biennial Global Survey of plastic surgeons and procedures

The International Society of Aesthetic Plastic Surgery is a world leader in plastic surgery. After a year-long process, the Society has produced the "ISAPS Biennial Global Surve" of plastic surgeons and procedures in the top 25 countries and regions – representing 75% of all procedures in 2009.The ISAPS Survey marks the first time reliable international plastic surgery data has been obtained and analyzed by independent statistical specialists.

9 Aug 2010

SIRIUS XM Radio to broadcast call-in show for autism spectrum disorders

SIRIUS XM Radio today announced that in partnership with Autism Speaks it will broadcast Doctor Radio Reports: Understanding Autism - Looking for Answers, a live, two-hour call-in show hosted by veteran journalist Perri Peltz on which a panel of world-class doctors, experts, scientists and parents of affected children will explore the latest research and treatment options for autism and disorders on the autism spectrum and take calls from listeners across the country.

7 Aug 2010

Reality TV shows take full advantage, tout teen happiness: Research

Teenage years have long been linked with a heightened concern with appearance. Some reality TV shows take full advantage and tout happiness as just a nip/tuck away. A Rutgers-Camden psychologist has found that teens fond of these kinds of programs are more likely to join the millions who go under the knife each year. For bodies - and minds - still in development, these drastic decisions could have implications way after prom.

31 Jul 2010

CryoLife second-quarter revenues increase 4% to record $29.3 million

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today its results for the second quarter of 2010. Revenues for the second quarter increased 4 percent to a second quarter record of $29.3 million compared to $28.2 million for the second quarter of 2009. Net income for the second quarter of 2010 was $2.9 million, or $0.10 per basic and fully diluted common share, compared to $2.5 million, or $0.09 per basic and fully diluted common share, for the second quarter of 2009.

30 Jul 2010